8-KThe WireRoutine
Bylaw Amendment
Filed Dec 2, 2022 · 3y ago · Accession 0001193125-22-297530
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Karyopharm Therapeutics Inc.
- Ticker
- KPTI
- CIK
- 1503802
- Form type
- 8-K
- Filing date
- Dec 2, 2022
- Report date
- Dec 2, 2022
- Document
- d423713d8k.htm
- Size
- 307 KB